福瑞医科
(300049)
| 流通市值：96.01亿 | | | 总市值：108.50亿 |
| 流通股本：2.34亿 | | | 总股本：2.64亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,141,439,239.95 | 754,789,476.99 | 360,140,767.62 | 1,595,388,937.81 |
| 营业总成本 | 842,216,150.29 | 580,721,995.02 | 276,499,345 | 1,213,306,309.13 |
| 其他经营收益 | | | | |
| 营业利润 | 301,328,819.33 | 168,565,506.3 | 78,984,552.27 | 368,296,564.27 |
| 利润总额 | 290,010,413.9 | 159,448,574.26 | 73,080,672.1 | 350,561,476.24 |
| 净利润 | 216,242,783.82 | 114,532,235.09 | 52,122,335.12 | 258,420,785.01 |
| 每股收益 | | | | |
| 其他综合收益 | -103,916,570.86 | -67,800,752.91 | -47,067,187.84 | 98,609,354.51 |
| 综合收益总额 | 112,326,212.96 | 46,731,482.18 | 5,055,147.28 | 357,030,139.52 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,511,296,469.25 | 1,486,694,973.81 | 1,518,718,935.53 | 1,544,517,136.86 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,957,108,057.05 | 1,979,407,915.34 | 1,901,897,169.85 | 1,894,398,310.98 |
| 资产总计 | 3,468,404,526.3 | 3,466,102,889.15 | 3,420,616,105.38 | 3,438,915,447.84 |
| 流动负债: | | | | |
| 流动负债合计 | 436,002,189.11 | 468,694,649.75 | 441,561,555.5 | 482,247,073.85 |
| 非流动负债: | | | | |
| 非流动负债合计 | 502,122,519.3 | 512,068,524.51 | 498,501,764.03 | 485,083,666.24 |
| 负债合计 | 938,124,708.41 | 980,763,174.26 | 940,063,319.53 | 967,330,740.09 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,990,228,244.69 | 1,965,328,708.73 | 1,981,795,103.1 | 1,978,323,925.45 |
| 股东权益合计 | 2,530,279,817.89 | 2,485,339,714.89 | 2,480,552,785.85 | 2,471,584,707.75 |
| 负债和股东权益合计 | 3,468,404,526.3 | 3,466,102,889.15 | 3,420,616,105.38 | 3,438,915,447.84 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,235,253,423.06 | 850,942,301.35 | 414,263,173.57 | 1,598,932,352.84 |
| 经营活动现金流出小计 | 963,902,146.39 | 674,616,186.18 | 322,582,268.56 | 1,247,407,283.81 |
| 经营活动产生的现金流量净额 | 271,351,276.67 | 176,326,115.17 | 91,680,905.01 | 351,525,069.03 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 611,046,843.86 | 441,485,187.68 | 190,402,495.32 | 1,376,248,042.63 |
| 投资活动现金流出小计 | 829,434,752.89 | 580,831,751.96 | 253,359,125.74 | 1,589,279,701.46 |
| 投资活动产生的现金流量净额 | -218,387,909.03 | -139,346,564.28 | -62,956,630.42 | -213,031,658.83 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 52,095,371.8 | 51,729,569.45 | 11,500,000 | 13,744,130.32 |
| 筹资活动现金流出小计 | 84,077,802.9 | 35,733,309.97 | 9,699,021.46 | 84,005,363.37 |
| 筹资活动产生的现金流量净额 | -31,982,431.1 | 15,996,259.48 | 1,800,978.54 | -70,261,233.05 |
| 汇率变动对现金及现金等价物的影响 | -36,728,724.79 | -27,288,343.08 | -17,723,625.72 | 12,260,974.72 |
| 现金及现金等价物净增加额 | -15,747,788.25 | 25,687,467.29 | 12,801,627.41 | 80,493,151.87 |
| 期末现金及现金等价物余额 | 624,531,946.97 | 665,967,202.51 | 653,081,362.63 | 640,279,735.22 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 25,687,467.29 | - | 80,493,151.87 |
最新报告期：2026-09-16| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华源证券 | 刘闯 | 0.76 | 1.01 | 1.40 | 2026-09-16 |